In this blog for people with Raynaud’s phenomenon, Dr Kevin Su, a Rheumatologist from Australia, looks at the latest Cochrane evidence on vasodilator drugs for Primary Raynaud’s phenomenon. Katie LeBlanc, a patient advocate, reflects on her experiences.
Cardiovascular & vascular
In this blog for people with normal or high blood pressure (hypertension), Dr Rebecca Gould, Cochrane UK Fellow and Sport and Exercise Medicine Registrar, looks at the latest Cochrane evidence on walking for lowering blood pressure.
Robert Walton, a Cochrane UK Senior Fellow in General Practice, blogs about the evidence on reducing saturated fat in...
Dr Rebecca Gould, Sport and Exercise Medicine Registrar and Cochrane UK Fellow, looks at the latest Cochrane evidence on exercise for intermittent claudication (lower leg pain that comes on during exercise) and explores if the type of exercise undertaken makes a difference.
Cardiologists Will Watson and Harry Boardman blog about Cochrane evidence comparing two treatments for aortic stenosis in people with low surgical risk.
A blog for people with arterio-venous malformations (AVMs) on Cochrane evidence to inform their decisions about treatment.
Robert Walton, a Cochrane UK Senior Fellow in General Practice, looks at the latest Cochrane evidence on what blood pressure targets to aim for, balancing the benefits of treatment against risk of side effects.
Harry Boardman discusses the different types of coronary stents which are used to treat people after a heart attack.
This article for nurses, on venous leg ulcers, is one of a series of evidence reviews written by Sarah Chapman for the British Journal of Community Nursing
In a blog for medical trainees, Chris McAloon, a cardiology specialty trainee, reflects on evidence and practice for treating someone with ST elevation myocardial infarction (STEMI)
Sarah Chapman reflects on how Cochrane UK used social media to share Cochrane evidence on replacement of peripheral venous catheters with nurses
Cardiologist Vinod Achan reflects on a Cochrane review on the effectiveness and safety of ablation as an alternative to drug treatment for atrial fibrillation